HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 168 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $1,538,000 | -30.2% | 120,000 | -29.4% | 0.22% | -36.7% |
Q1 2017 | $2,203,000 | +23.9% | 170,000 | -5.6% | 0.35% | +2.3% |
Q4 2016 | $1,778,000 | -99.9% | 180,000 | -28.0% | 0.34% | -29.0% |
Q3 2016 | $3,020,000,000 | +139844.4% | 250,000 | 0.0% | 0.48% | +25.3% |
Q2 2016 | $2,158,000 | -47.1% | 250,000 | -42.0% | 0.38% | -52.7% |
Q1 2016 | $4,082,000 | -42.5% | 431,000 | +5.1% | 0.81% | -24.6% |
Q4 2015 | $7,105,000 | +207.6% | 410,000 | +138.4% | 1.07% | +191.8% |
Q3 2015 | $2,310,000 | -40.5% | 172,000 | 0.0% | 0.37% | -21.0% |
Q2 2015 | $3,884,000 | – | 172,000 | – | 0.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |